Search Results

FDA Approves Breyanzi for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Subjects: THERAPEUTIC use of antineoplastic agents; CHRONIC lymphocytic leukemia; PROTEIN-tyrosine kinase inhibitorsUNITED States. Food & Drug Administration

• Source: Formulary Watch. 3/15/2024, p1-2. 2p.

Record details

FDA Approves Jaypirca for Leukemia/Lymphoma Indication.

Subjects: *DRUG labeling; THERAPEUTIC use of antineoplastic agents; CHRONIC lymphocytic leukemiaUNITED StatesUNITED States. Food & Drug Administration

• Source: Formulary Watch. 12/4/2023, p1-2. 2p.

Record details

Case-Cohort Study of the Association between PFAS and Selected Cancers among Participants in the American Cancer Society's Cancer Prevention Study II LifeLink Cohort.

• Authors : Winquist, Andrea¹ ; Hodge, James M.²; Diver, W. Ryan²

Subjects: *Pollutants; *Fluorocarbons; Tumor risk factorsAmerican Cancer Society Inc.

• Source: Environmental Health Perspectives. Dec2023, Vol. 131 Issue 12, p127007-1-127007-14. 14p.

Record details

One Patient's Guide to Understanding and Navigating the CLL Journey.

• Authors : Friesen, Sonya (AUTHOR)

Subjects: *MEDICAL offices; CHRONIC lymphocytic leukemia

• Source: Maclean's. Oct2023, Vol. 136 Issue 8, p(Sp)6-(Sp)6. 1p. 2 Color Photographs.

Record details

The importance of prognostic testing for patients with chronic lymphocytic leukemia.

• Authors : Kruzel, Mark

Subjects: *CHRONIC lymphocytic leukemia diagnosis; *CHRONIC lymphocytic leukemia; *CLINICAL pathology

• Source: Medical Laboratory Observer (MLO). Mar2024, Vol. 56 Issue 3, p19-35. 2p.

Record details

Chris Rose hopes his stint replacing Jim Donovan is a short one.

• Authors : Scalzo, Joe (AUTHOR)

Subjects: *ROSES; *CHRONIC lymphocytic leukemia

• Source: Crain's Cleveland Business. 9/18/2023, Vol. 44 Issue 34, p24-24. 1p.

Record details

Recurrent Primary Mucinous Carcinoma of the Skin.

• Authors : Tambe, Swagata Arvind¹; Patil, Priyanka Deelip² ; Jerajani, Hemangi³

Subjects: *MUCINOUS adenocarcinoma; *CHRONIC lymphocytic leukemia; *GASTROINTESTINAL system

• Source: Medical Journal of Dr. D.Y. Patil Vidyapeeth. 2023 Supplement 1, Vol. 16, pS166-S169. 4p.

Record details

HLH and TET2 Mutation Presenting after First Cycle of CLL Treatment.

• Authors : Geiger, Allison J.¹; Yasar, Demet Gokalp²; Sitwala, Kajal V.³

Subjects: *THERAPEUTIC use of antineoplastic agents; *CHRONIC lymphocytic leukemia; *RITUXIMAB

• Source: Clinical Medicine & Research. Sep2023, Vol. 21 Issue 3, p155-158. 4p.

Record details

Bristol Myers Wins FDA Approval of CAR-T for Some Blood Cancers.

• Authors : Cortez, Michelle Fay (AUTHOR)

Subjects: CHRONIC lymphocytic leukemiaUNITED States. Food & Drug Administration

• Source: Bloomberg.com. 3/14/2024, pN.PAG-N.PAG. 1p.

Record details

Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1–2 study.

• Authors : Siddiqi, Tanya (AUTHOR); Maloney, David G (AUTHOR); Kenderian, Saad S (AUTHOR)

Subjects: LYMPHOCYTIC leukemia; JUNO Therapeutics Inc.; CHRONIC leukemia

• Source: Lancet. Aug2023, Vol. 402 Issue 10402, p641-654. 14p.

Record details